Stockreport

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF US$0.28 loss per share (improved from US$0.46 loss in 3Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded ana [Read more]